Nav: Home

Non-invasive imaging technique valid for identifying small airway disease in lung

March 14, 2019

Chronic obstructive pulmonary disease (COPD), an inflammatory disease of the small airways in the lungs, affects 16 million Americans and is the fourth leading cause of death in the United States, according to the National Heart Lung and Blood Institute (NHLBI). Identifying small airway disease in its earliest stages, when it is most treatable, could potentially lead to new drug therapies for those with COPD, researchers say.

However, it has been difficult for physicians to identify abnormalities of the small airways non-invasively; the tiny bronchioles that are first damaged in COPD, which are less than 2 mm in internal diameter, are simply too small to be visualized on CT imaging, and are not well-reflected by pulmonary function tests.

In a landmark study funded by the NHLBI, an international team of researchers led by Michigan Medicine confirmed the ability of a non-invasive imaging biomarker to identify small airway damage in COPD.

In the American Journal of Respiratory and Critical Care Medicine, the researchers report on the ability of a relatively new technique, called Parametric Response Mapping (PRM), to identify small airway abnormality in COPD. Invented at Michigan Medicine, the University of Michigan's academic medical center, by Brian Ross, Ph.D., professor of radiology and biological chemistry and Craig Galban, Ph.D., associate professor of radiology, PRM is a non-invasive technique that measures lung density during inhalation and exhalation.

The team examined lung tissue from patients with COPD undergoing lung transplantation as well as those with healthy donated tissue. Researchers then mapped those samples back to the CT scans taken before surgery.

They confirmed that PRM was able to non-invasively identify small airway loss, narrowing and obstruction. This technical feat required the collaboration of large, multi-disciplinary teams of radiologists, pulmonologists, thoracic surgeons and pathologists in multiple locations across two countries, all activated around the clock due to the unpredictable nature of transplant surgery.

Senior author MeiLan Han, M.D., a lung specialist and professor of internal medicine at the University of Michigan, says, "Now we have confidence in our ability to identify airway disease when imaging COPD patients. PRM is already clinically available and used by University of Michigan clinical teams to assess patients with COPD. This is what we mean by bench to bedside medicine."

While these studies were performed in patients with severe disease, in another NHLBI funded study, COPDGene, the PRM-defined small airway abnormalities have been detected on CT scans of patients with milder disease and help to predict patients who will lose lung function. Han notes, however, "We still need to validate the type of airway disease the PRM technique identifies in patients with milder disease. That type of lung tissue is more difficult to obtain, but we are working on techniques that would allow us to use smaller amounts of lung tissue to make such studies feasible."

Currently, there is no cure for or way to reverse COPD. Lifestyle changes, like quitting smoking, and treatment with bronchodilators and inhaled steroids can help expand airways and reduce inflammation. Surgery to remove damaged lung tissue and lung transplantation are options for some patients with severe disease. By helping to identify patients at risk for disease progression, PRM can serve as a non-invasive measure to aid clinical trials of new therapeutics, the researchers concluded.

"These results illustrate the importance of developing non-invasive techniques for improving diagnostic capabilities and advancing new therapies needed to tackle this devastating disease," says James Kiley, Ph.D., director of the Division of Lung Diseases at the National Heart, Lung, and Blood Institute. "The refinement of this and similar approaches could also advance the study of COPD at its earliest stages of development."
-end-
Additional authors: Vasilescu DM, PhD, University of British Columbia, Vancouver, Canada; Martinez FJ, MD, Weill Cornell Medical College, New York, NY; Marchetti N, DO, Lewis Katz School of Medicine, Temple University, Philadelphia, PA; Galban CJ, PhD, University of Michigan, Ann Arbor, MI; Hatt, C, PhD, University of Michigan, Ann Arbor, MI and Imbio, Minneapolis, MN; Meldrum C, PhD, University of Michigan, Ann Arbor, MI; Dass Chandra, MD, Lewis Katz School of Medicine, Temple University, Philadelphia, PA; Tanabe N, MD, Kyoto University, Kyoto, Japan; Reddy R, MD, University of Michigan, Ann Arbor, MI; Lagstein A, MD, University of Michigan, Ann Arbor, MI; Ross BD, PhD, University of Michigan, Ann Arbor, MI; Labaki WW, MD, University of Michigan, Ann Arbor, MI; Murray S, ScD, University of Michigan, Ann Arbor, MI; Meng X, University of Michigan, Ann Arbor, MI; Curtis JL, MD, University of Michigan, Ann Arbor, MI and VA Ann Arbor Healthcare System, Ann Arbor, MI; Hackett TL, PhD, University of British Columbia, Vancouver, Canada; Kazerooni E, MD, University of Michigan, Ann Arbor, MI; Criner GJ, MD, Lewis Katz School of Medicine, Temple University, Philadelphia, PA; Hogg JC, MD, University of British Columbia, Vancouver, Canada.

Funding: Han: NIH RO1 HL122328, NIH K24 HL138188; Vasilescu: Canadian Thoracic Society and Alpha-1 Foundation; Hackett: Canadian Institutes for Health Research and Michael Smith Foundation for Health Research; Curtis: Department of Veterans Affairs Merit Review I01 CX000911, NIH RO1 AI120526 and NIH R21 AI 117371; Ross: NIH R35 CA197701.

Michigan Medicine - University of Michigan

Related Copd Articles:

Treatment seeks to address exacerbations of COPD
A new study finds that delivery of oxygen via high-flow nasal tubes may help patients who experience exacerbations of chronic obstructive pulmonary disease (COPD).
Study reveals surprises concerning COPD and smoking
A new study challenges the widely accepted but oversimplified description of airway inflammation in smokers and patients with chronic obstructive pulmonary disease (COPD).
New guidelines for treatment and management of COPD exacerbations
A multi-disciplinary ERS/ATS task force of chronic obstructive pulmonary disease (COPD) experts has published comprehensive new guidelines on the treatment of COPD exacerbations.
New genetic markers for COPD discovered
In a new Research Letter published in Nature Genetics on Feb.
COPD -- what causes the lungs to lose their ability to heal?
In chronic obstructive pulmonary disease (COPD), the patients' lungs lose their ability to repair damages on their own.
New technology detects COPD in minutes
Pioneering research by Professor Paul Lewis of Swansea University's Medical School into one of the most common lung diseases in the UK, Chronic Obstructive Pulmonary Disease, has led to the development of a new technology that can quickly and easily diagnose and monitor the condition.
COPD exacerbations lead to lung function decline, particularly among those with mild COPD
Acute exacerbations of chronic obstructive pulmonary disease, or COPD, are associated with significant long-term lung function loss, according to research published online, ahead of print in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Depression decreases adherence to COPD maintenance medications
A recent study in the Annals of the American Thoracic Society found that in a nationally representative sample of Medicare beneficiaries who were newly diagnosed with COPD, adherence to maintenance medications decreased with new episodes of depression.
Care for COPD: Could more be done?
Meilan Han, M.D., an associate professor of internal medicine at the University of Michigan and the medical director of the U-M Women's Respiratory Health Program, is the lead author on a new report that set out to provide a comprehensive view of COPD care in the US.
COPD symptoms common among smokers, even when undiagnosed
A new study in the New England Journal of Medicine finds that smokers, who wouldn't typically be diagnosed with chronic obstructive pulmonary disease, or COPD, are still showing symptoms consistent with the diagnosis.

Related Copd Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...